{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:12:21Z","timestamp":1793211141860,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":191,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811377082","type":"print"},{"value":"9789811377099","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7709-9_13","type":"book-chapter","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:57:22Z","timestamp":1567537042000},"page":"279-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice"],"prefix":"10.1007","author":[{"given":"S. A.","family":"Bowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"1\u20132","key":"13_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2018.07.006","volume":"125","author":"T Akiyama","year":"2018","unstructured":"Akiyama T, Kubota T, Ozono K, Michigami T, Kobayashi D, Takeyari S, Sugiyama Y, Noda M, Harada D, Namba N et al (2018) Pyridoxal 5\u2032-phosphate and related metabolites in hypophosphatasia: effects of enzyme replacement therapy. Mol Genet Metab 125(1\u20132):174\u2013180","journal-title":"Mol Genet Metab"},{"issue":"1","key":"13_CR2","first-page":"49","volume":"37","author":"A Albeggiani","year":"1982","unstructured":"Albeggiani A, Cataldo F (1982) Infantile hypophosphatasia diagnosed at 4 months and surviving at 2 years. Helv Paediatr Acta 37(1):49\u201358","journal-title":"Helv Paediatr Acta"},{"issue":"3","key":"13_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)63172-0","volume":"164","author":"HC Anderson","year":"2004","unstructured":"Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL, Dhamyamraju R (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164(3):841\u2013847","journal-title":"Am J Pathol"},{"issue":"6","key":"13_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0002-9440(10)62481-9","volume":"166","author":"HC Anderson","year":"2005","unstructured":"Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millan JL (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase\/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166(6):1711\u20131720","journal-title":"Am J Pathol"},{"issue":"7","key":"13_CR5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ajmg.a.36001","volume":"161A","author":"L Armstrong","year":"2013","unstructured":"Armstrong L, Jett K, Birch P, Kendler DL, McKay H, Tsang E, Stevenson DA, Hanley DA, Egeli D, Burrows M et al (2013) The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study. Am J Med Genet A 161A(7):1654\u20131661","journal-title":"Am J Med Genet A"},{"issue":"16","key":"13_CR6","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1097\/01.brs.0000174277.03526.de","volume":"30","author":"R Arun","year":"2005","unstructured":"Arun R, Khazim R, Webb JK, Burn J (2005) Scoliosis in association with infantile hypophosphatasia: a case study in two siblings. Spine 30(16):E471\u2013E476","journal-title":"Spine"},{"key":"13_CR01","doi-asserted-by":"crossref","unstructured":"Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Burgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Hogler W (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677t>c, p.M226t; c.1112c>t, p.T371i) of the tissue-nonspecific alkaline phosphatase gene. Bone 40(6):1655\u20131661","DOI":"10.1016\/j.bone.2007.01.020"},{"issue":"3","key":"13_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-008-0710-9","volume":"29","author":"C Beck","year":"2009","unstructured":"Beck C, Morbach H, Richl P, Stenzel M, Girschick H (2009) How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases? Rheumatol Int 29(3):229\u2013238","journal-title":"Rheumatol Int"},{"issue":"6","key":"13_CR8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/00220345990780060501","volume":"78","author":"W Beertsen","year":"1999","unstructured":"Beertsen W, VandenBos T, Everts V (1999) Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation. J Dent Res 78(6):1221\u20131229","journal-title":"J Dent Res"},{"issue":"1","key":"13_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54(1):21\u201327","journal-title":"Bone"},{"issue":"4","key":"13_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0022034516677528","volume":"96","author":"M Biosse Duplan","year":"2017","unstructured":"Biosse Duplan M, Coyac BR, Bardet C, Zadikian C, Rothenbuhler A, Kamenicky P, Briot K, Linglart A, Chaussain C (2017) Phosphate and vitamin d prevent periodontitis in x-linked hypophosphatemia. J Dent Res 96(4):388\u2013395","journal-title":"J Dent Res"},{"issue":"6","key":"13_CR11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0003-9969(68)90146-5","volume":"13","author":"S Bisaz","year":"1968","unstructured":"Bisaz S, Russell RG, Fleisch H (1968) Isolation of inorganic pyrophosphate from bovine and human teeth. Arch Oral Biol 13(6):683\u2013696","journal-title":"Arch Oral Biol"},{"issue":"6","key":"13_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ipd.12232","volume":"26","author":"A Bloch-Zupan","year":"2016","unstructured":"Bloch-Zupan A (2016) Hypophosphatasia: diagnosis and clinical signs\u00a0\u2013 a dental surgeon perspective. Int J Paediatr Dent 26(6):426\u2013438","journal-title":"Int J Paediatr Dent"},{"issue":"Pt 3","key":"13_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3550707","volume":"355","author":"G Boileau","year":"2001","unstructured":"Boileau G, Tenenhouse HS, Desgroseillers L, Crine P (2001) Characterization of phex endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107\u2013139 as a substrate and osteocalcin, ppi and phosphate as inhibitors. Biochem J 355(Pt 3):707\u2013713","journal-title":"Biochem J"},{"issue":"2","key":"13_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-017-4267-x","volume":"29","author":"SA Bowden","year":"2018","unstructured":"Bowden SA, Adler BH (2018a) Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporos Int 29(2):511\u2013515","journal-title":"Osteoporos Int"},{"issue":"9","key":"13_CR15","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00198-018-4613-7","volume":"29","author":"SA Bowden","year":"2018","unstructured":"Bowden SA, Adler BH (2018b) Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia. Osteoporos Int 29(9):2155\u20132156","journal-title":"Osteoporos Int"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0030-4220(62)90356-0","volume":"15","author":"R Bruckner","year":"1962","unstructured":"Bruckner R, Rickles N, Porter D (1962) Hypophosphatasia with premature shedding of teeth and aplasia of cementum. Oral Surg Oral Med Oral Pathol 15:1351\u20131369","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"8","key":"13_CR17","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1210\/jc.2006-2131","volume":"92","author":"RA Cahill","year":"2007","unstructured":"Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH, Mumm S, Whyte MP (2007) Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 92(8):2923\u20132930","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 1","key":"13_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","volume":"373","author":"M Campos","year":"2003","unstructured":"Campos M, Couture C, Hirata IY, Juliano MA, Loisel TP, Crine P, Juliano L, Boileau G, Carmona AK (2003) Human recombinant endopeptidase phex has a strict s1\u2019 specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein. Biochem J 373(Pt 1):271\u2013279","journal-title":"Biochem J"},{"issue":"48","key":"13_CR19","doi-asserted-by":"crossref","first-page":"e13269","DOI":"10.1097\/MD.0000000000013269","volume":"97","author":"L Castells","year":"2018","unstructured":"Castells L, Cassanello P, Mu\u00f1iz F, de Castro M-J, Couce ML (2018) Neonatal lethal hypophosphatasia: a case report and review of literature. Medicine 97(48):e13269","journal-title":"Medicine"},{"issue":"3","key":"13_CR20","first-page":"493","volume":"66","author":"JS Clubb","year":"1965","unstructured":"Clubb JS, Neale FC, Posen S (1965) The behavior of infused human placental alkaline phosphatase in human subjects. J Lab Clin Med 66(3):493\u2013507","journal-title":"J Lab Clin Med"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00198-018-4714-3","volume":"30","author":"JM Colazo","year":"2018","unstructured":"Colazo JM, Hu JR, Dahir KM, Simmons JH (2018) Correction to: neurological symptoms in hypophosphatasia. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 30:535","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"S2","key":"13_CR22","doi-asserted-by":"crossref","first-page":"P99","DOI":"10.1359\/jbmr.06s219","volume":"21","author":"MT Collins","year":"2006","unstructured":"Collins MT (2006) Spectrum and natural history of fibrous dysplasia of bone. J Bone Miner Res 21(S2):P99\u2013P104","journal-title":"J Bone Miner Res"},{"issue":"2","key":"13_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00381-008-0708-3","volume":"25","author":"H Collmann","year":"2009","unstructured":"Collmann H, Mornet E, Gattenlohner S, Beck C, Girschick H (2009) Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst 25(2):217\u2013223","journal-title":"Childs Nerv Syst"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgmr.2017.10.006","volume":"14","author":"G Costain","year":"2018","unstructured":"Costain G, Moore AM, Munroe L, Williams A, Shaul RZ, Rockman-Greenberg C, Offringa M, Kannu P (2018) Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice. Mol Genet Metab Rep 14:22\u201326","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"13_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.13950","volume":"140","author":"T Cruz","year":"2017","unstructured":"Cruz T, Gleizes M, Balayssac S, Mornet E, Marsal G, Millan JL, Malet-Martino M, Nowak LG, Gilard V, Fonta C (2017) Identification of altered brain metabolites associated with tnap activity in a mouse model of hypophosphatasia using untargeted nmr-based metabolomics analysis. J Neurochem 140(6):919\u2013940","journal-title":"J Neurochem"},{"issue":"9","key":"13_CR26","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/jbmr.2495","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T, Michigami T, Tachikawa K, Dray M, Collins JF, Paschalis EP, Gamsjaeger S, Roschger A, Fratzl-Zelman N, Roschger P et al (2015) Reversible deterioration in hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res 30(9):1726\u20131737","journal-title":"J Bone Miner Res"},{"issue":"4","key":"13_CR27","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1542\/peds.2013-0733","volume":"133","author":"T Davit-Beal","year":"2014","unstructured":"Davit-Beal T, Gabay J, Antoniolli P, Masle-Farquhar J, Wolikow M (2014) Dental complications of rickets in early childhood: case report on 2 young girls. Pediatrics 133(4):e1077\u2013e1081","journal-title":"Pediatrics"},{"issue":"8","key":"13_CR28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nm.3583","volume":"20","author":"J de la Croix Ndong","year":"2014","unstructured":"de la Croix Ndong J, Makowski AJ, Uppuganti S, Vignaux G, Ono K, Perrien DS, Joubert S, Baglio SR, Granchi D, Stevenson DA et al (2014) Asfotase-alpha improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1. Nat Med 20(8):904\u2013910","journal-title":"Nat Med"},{"issue":"6","key":"13_CR29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1651-2227.2000.tb00374.x","volume":"89","author":"AA Deeb","year":"2000","unstructured":"Deeb AA, Bruce SN, Morris AA, Cheetham TD (2000) Infantile hypophosphatasia: disappointing results of treatment. Acta Paediatr (Oslo, Norway: 1992) 89(6):730\u2013733","journal-title":"Acta Paediatr (Oslo, Norway: 1992)"},{"issue":"6148","key":"13_CR30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/330576a0","volume":"330","author":"T Doetschman","year":"1987","unstructured":"Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, Thompson S, Smithies O (1987) Targetted correction of a mutant hprt gene in mouse embryonic stem cells. Nature 330(6148):576\u2013578","journal-title":"Nature"},{"issue":"3","key":"13_CR31","first-page":"266","volume":"6","author":"KB Doshi","year":"2009","unstructured":"Doshi KB, Hamrahian AH, Licata AA (2009) Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. Clin Cases Miner Bone Metab 6(3):266\u2013269","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"9","key":"13_CR32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.braindev.2008.02.002","volume":"30","author":"O Duman","year":"2008","unstructured":"Duman O, Ozdem S, Turkkahraman D, Olgac ND, Gungor F, Haspolat S (2008) Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain Dev 30(9):584\u2013588","journal-title":"Brain Dev"},{"issue":"2","key":"13_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/dvdy.24370","volume":"245","author":"J Durussel","year":"2016","unstructured":"Durussel J, Liu J, Campbell C, Nam HK, Hatch NE (2016) Bone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasia. Dev Dyn 245(2):175\u2013182","journal-title":"Dev Dyn"},{"issue":"10","key":"13_CR34","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","volume":"149A","author":"F Elefteriou","year":"2009","unstructured":"Elefteriou F, Kolanczyk M, Schindeler A, Viskochil DH, Hock JM, Schorry EK, Crawford AH, Friedman JM, Little D, Peltonen J et\u00a0al (2009) Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A 149A(10):2327\u20132338","journal-title":"Am J Med Genet A"},{"issue":"1","key":"13_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.a.33146","volume":"152a","author":"AH El-Gharbawy","year":"2010","unstructured":"El-Gharbawy AH, Peeden JN Jr, Lachman RS, Graham JM Jr, Moore SR, Rimoin DL (2010) Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the c-terminal region of runx2. Am J Med Genet A 152a(1):169\u2013174","journal-title":"Am J Med Genet A"},{"issue":"5819","key":"13_CR36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/292154a0","volume":"292","author":"MJ Evans","year":"1981","unstructured":"Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154\u2013156","journal-title":"Nature"},{"issue":"12","key":"13_CR37","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","volume":"14","author":"KN Fedde","year":"1999","unstructured":"Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14(12):2015\u20132026","journal-title":"J Bone Miner Res"},{"issue":"12","key":"13_CR38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.bdj.2018.441","volume":"224","author":"C Feeney","year":"2018","unstructured":"Feeney C, Stanford N, Lee S, Barry S (2018) Hypophosphatasia and the importance of the general dental practitioner\u00a0\u2013 a case series and discussion of upcoming treatments. Br Dent J 224(12):937\u2013943","journal-title":"Br Dent J"},{"issue":"Suppl 1","key":"13_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03008200390152061","volume":"44","author":"LW Fisher","year":"2003","unstructured":"Fisher LW, Fedarko NS (2003) Six genes expressed in bones and teeth encode the current members of the sibling family of proteins. Connect Tissue Res 44(Suppl 1):33\u201340","journal-title":"Connect Tissue Res"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1152\/ajplegacy.1962.203.4.671","volume":"203","author":"H Fleisch","year":"1962","unstructured":"Fleisch H, Bisaz S (1962a) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203:671\u2013675","journal-title":"Am J Physiol"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/195911a0","volume":"195","author":"H Fleisch","year":"1962","unstructured":"Fleisch H, Bisaz S (1962b) Mechanism of calcification: inhibitory role of pyrophosphate. Nature 195:911","journal-title":"Nature"},{"issue":"5003","key":"13_CR42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/2071300b0","volume":"207","author":"H Fleisch","year":"1965","unstructured":"Fleisch H, Schibler D, Maerki J, Frossard I (1965) Inhibition of aortic calcification by means of pyrophosphate and polyphosphates. Nature 207(5003):1300\u20131301","journal-title":"Nature"},{"issue":"5065","key":"13_CR43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","volume":"212","author":"H Fleisch","year":"1966","unstructured":"Fleisch H, Russell RG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212(5065):901\u2013903","journal-title":"Nature"},{"key":"13_CR44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/B978-0-12-809965-0.00029-X","volume-title":"Vitamin d","author":"BL Foster","year":"2018","unstructured":"Foster BL, Hujoel PP (2018) Vitamin d in dentoalveolar and oral health. In: Feldman D, Pike JW, Bouillon R (eds) Vitamin d, 4th edn. Academic, London, pp 497\u2013520","edition":"4"},{"issue":"6","key":"13_CR45","doi-asserted-by":"crossref","first-page":"e38393","DOI":"10.1371\/journal.pone.0038393","volume":"7","author":"BL Foster","year":"2012","unstructured":"Foster BL, Nagatomo KJ, Nociti FH Jr, Fong H, Dunn D, Tran AB, Wang W, Narisawa S, Millan JL, Somerman MJ (2012) Central role of pyrophosphate in acellular cementum formation. PLoS One 7(6):e38393","journal-title":"PLoS One"},{"issue":"2","key":"13_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jbmr.1767","volume":"28","author":"BL Foster","year":"2013","unstructured":"Foster BL, Nagatomo KJ, Tso HW, Tran AB, Nociti FH Jr, Narisawa S, Yadav MC, McKee MD, Millan JI, Somerman MJ (2013) Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res 28(2):271\u2013282","journal-title":"J Bone Miner Res"},{"issue":"5","key":"13_CR47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/0022034515573273","volume":"94","author":"BL Foster","year":"2015","unstructured":"Foster BL, Sheen CR, Hatch NE, Liu J, Cory E, Narisawa S, Kiffer-Moreira T, Sah RL, Whyte MP, Somerman MJ et al (2015) Periodontal defects in the a116t knock-in murine model of odontohypophosphatasia. J Dent Res 94(5):706\u2013714","journal-title":"J Dent Res"},{"issue":"1","key":"13_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0022034516663633","volume":"96","author":"BL Foster","year":"2017","unstructured":"Foster BL, Kuss P, Yadav MC, Kolli TN, Narisawa S, Lukashova L, Cory E, Sah RL, Somerman MJ, Millan JL (2017) Conditional alpl ablation phenocopies dental defects of hypophosphatasia. J Dent Res 96(1):81\u201391","journal-title":"J Dent Res"},{"issue":"48","key":"13_CR49","doi-asserted-by":"crossref","first-page":"e13210","DOI":"10.1097\/MD.0000000000013210","volume":"97","author":"TQ Freitas","year":"2018","unstructured":"Freitas TQ, Franco AS, Pereira RMR (2018) Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: case report. Medicine 97(48):e13210","journal-title":"Medicine"},{"key":"13_CR50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bone.2014.11.017","volume":"72","author":"KC Gasque","year":"2015","unstructured":"Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millan JL (2015) Improvement of the skeletal and dental hypophosphatasia phenotype in alpl\u2212\/\u2212 mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone 72:137\u2013147","journal-title":"Bone"},{"key":"13_CR51","doi-asserted-by":"crossref","unstructured":"Genest F, Seefried L (2018) Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia\u2014not atypical at all. Osteoporos Int 1\u201311","DOI":"10.1007\/s00198-018-4552-3"},{"issue":"1","key":"13_CR52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-1-24","volume":"1","author":"H Girschick","year":"2006","unstructured":"Girschick H, Schneider P, Haubitz I, Hiort O, Collmann H, Beer M, Shin Y, Seyberth H (2006) Effective nsaid treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis 1(1):24","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"13_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2431-7-3","volume":"7","author":"HJ Girschick","year":"2007","unstructured":"Girschick HJ, Mornet E, Beer M, Warmuth-Metz M, Schneider P (2007) Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr 7(1):3","journal-title":"BMC Pediatr"},{"issue":"5","key":"13_CR54","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1042\/bj0181161","volume":"18","author":"HW Goodwin","year":"1924","unstructured":"Goodwin HW, Robison R (1924) The possible significance of hexosephosphoric esters in ossification. Part iv. The phosphoric esters of the blood: preliminary communication. Biochem J 18(5):1161\u20131162","journal-title":"Biochem J"},{"issue":"1","key":"13_CR55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/geno.1993.1305","volume":"17","author":"CR Greenberg","year":"1993","unstructured":"Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, Chodirker BN (1993) A homoallelic gly317\u00a0\u2013 >asp mutation in alpl causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics 17(1):215\u2013217","journal-title":"Genomics"},{"issue":"8","key":"13_CR56","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1359\/jbmr.060515","volume":"21","author":"K Gurley","year":"2006","unstructured":"Gurley K, Chen H, Guenther C, Nguyen E, Rountree R, Schoor M, Kingsley D (2006) Mineral formation in joints caused by complete or joint-specific loss of ank function. J Bone Miner Res 21(8):1238\u20131247","journal-title":"J Bone Miner Res"},{"issue":"4","key":"13_CR57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI100974","volume":"17","author":"AB Gutman","year":"1938","unstructured":"Gutman AB, Gutman EB (1938) An \u201cacid\u201d phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17(4):473\u2013478","journal-title":"J Clin Invest"},{"key":"13_CR58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4274\/jcrpe.5166","volume":"10","author":"B Hacihamdioglu","year":"2018","unstructured":"Hacihamdioglu B, Ozgurhan G, Pereira C, Tepeli E, Acar G, Comert S (2018) Perinatal form hypophosphatasia caused by a novel large duplication of alpl gene and one year follow-up under enzyme replacement therapy; a case report. J Clin Res Pediatr Endocrinol 10:175\u2013178","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"13_CR59","unstructured":"Hall B, Limaye A, Kulkarni AB (2009) Overview: generation of gene knockout mice. Curr Protoct Cell Biol. Chapter 19:Unit 19 12 19 12 11\u201317"},{"issue":"4","key":"13_CR60","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","volume":"164","author":"D Harmey","year":"2004","unstructured":"Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164(4):1199\u20131209","journal-title":"Am J Pathol"},{"issue":"9","key":"13_CR61","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1359\/jbmr.060619","volume":"21","author":"D Harmey","year":"2006","unstructured":"Harmey D, Johnson KA, Zelken J, Camacho NP, Hoylaerts MF, Noda M, Terkeltaub R, Millan JL (2006) Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in akp2(\u2212\/\u2212) mice. J Bone Miner Res 21(9):1377\u20131386","journal-title":"J Bone Miner Res"},{"issue":"14","key":"13_CR62","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 99(14):9445\u20139449","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5477","key":"13_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.289.5477.265","volume":"289","author":"A Ho","year":"2000","unstructured":"Ho A, Johnson M, Kingsley D (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289(5477):265\u2013270","journal-title":"Science"},{"issue":"3","key":"13_CR64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1600-0722.2000.108003189.x","volume":"108","author":"JC Hu","year":"2000","unstructured":"Hu JC, Plaetke R, Mornet E, Zhang C, Sun X, Thomas HF, Simmer JP (2000) Characterization of a family with dominant hypophosphatasia. Eur J Oral Sci 108(3):189\u2013194","journal-title":"Eur J Oral Sci"},{"issue":"12","key":"13_CR65","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/hum.2015.078","volume":"26","author":"O Iijima","year":"2015","unstructured":"Iijima O, Miyake K, Watanabe A, Miyake N, Igarashi T, Kanokoda C, Nakamura-Takahashi A, Kinoshita H, Noguchi T, Abe S et al (2015) Prevention of lethal murine hypophosphatasia by neonatal ex vivo gene therapy using lentivirally transduced bone marrow cells. Hum Gene Ther 26(12):801\u2013812","journal-title":"Hum Gene Ther"},{"key":"13_CR66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.omtm.2018.08.004","volume":"10","author":"R Ikeue","year":"2018","unstructured":"Ikeue R, Nakamura-Takahashi A, Nitahara-Kasahara Y, Watanabe A, Muramatsu T, Sato T, Okada T (2018) Bone-targeted alkaline phosphatase treatment of mandibular bone and teeth in lethal hypophosphatasia via an scaav8 vector. Mol Ther Methods Clin Dev 10:361\u2013370","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"13_CR67","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","volume":"279","author":"KA Johnson","year":"2000","unstructured":"Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates pc-1. Am J Physiol Regul Integr Comp Physiol 279(4):R1365\u2013R1377","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"13_CR68","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/ajplegacy.1970.218.6.1757","volume":"218","author":"A Jung","year":"1970","unstructured":"Jung A, Russel RG, Bisaz S, Morgan DB, Fleisch H (1970) Fate of intravenously injected pyrophosphate-32p in dogs. Am J Physiol 218(6):1757\u20131764","journal-title":"Am J Physiol"},{"issue":"3\u20134","key":"13_CR69","first-page":"755","volume":"18","author":"HD Kay","year":"1924","unstructured":"Kay HD, Robison R (1924) The possible significance of hexosephosphoric esters in ossification. Part iii: the action of the bone enzyme on the organic phosphorus compounds in blood. Biochem J 18(3\u20134):755\u2013764","journal-title":"Biochem J"},{"issue":"2","key":"13_CR70","doi-asserted-by":"crossref","first-page":"e89374","DOI":"10.1371\/journal.pone.0089374","volume":"9","author":"T Kiffer-Moreira","year":"2014","unstructured":"Kiffer-Moreira T, Sheen CR, Gasque KC, Bolean M, Ciancaglini P, van Elsas A, Hoylaerts MF, Millan JL (2014) Catalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potential. PLoS One 9(2):e89374","journal-title":"PLoS One"},{"key":"13_CR71","unstructured":"Kishnani PS, Madson KL, Whyte MP, Gayron M, Fujita K, Rockman-Greenberg C (2016) Biochemical and physical function outcomes in adolescents and adults with hypophosphatasia treated with asfotase alfa for up to 4 years: interim results from a phase ii study. Metabolic and genetic bone disorders. Endocrine Society, pp OR26-23-OR26-23"},{"key":"13_CR72","doi-asserted-by":"crossref","unstructured":"Kishnani PS, Rockman-Greenberg C, Denker AE, Moseley S, Whyte MP (2017a) Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results. Paper presented at: International conference on Children\u2019s Bone Health (ICCBH). Wurzberg","DOI":"10.1530\/boneabs.6.OC25"},{"issue":"1","key":"13_CR73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","volume":"122","author":"PS Kishnani","year":"2017","unstructured":"Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME (2017b) Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 122(1):4\u201317","journal-title":"Mol Genet Metab"},{"issue":"1","key":"13_CR74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cen.13343","volume":"87","author":"T Kitaoka","year":"2017","unstructured":"Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, Okada S, Fujiwara I, Kokaji M, Mochizuki H et al (2017) Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a japanese clinical trial. Clin Endocrinol 87(1):10\u201319","journal-title":"Clin Endocrinol"},{"issue":"5","key":"13_CR75","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jbm4.10052","volume":"2","author":"P Klidaras","year":"2018","unstructured":"Klidaras P, Severt J, Aggers D, Payne J, Miller PD, Ing SW (2018) Fracture healing in two adult patients with hypophosphatasia after asfotase alfa therapy. JBMR Plus 2(5):304\u2013307","journal-title":"JBMR Plus"},{"issue":"3","key":"13_CR76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.11138\/ccmbm\/2017.14.3.347","volume":"14","author":"JE Lawrence","year":"2017","unstructured":"Lawrence JE, Saeed D, Bartlett J, Carrothers AD (2017) Adult-onset hypophosphatasia diagnosed following bilateral atypical femoral fractures in a 55-year-old woman. Clin Cases Miner Bone Metab 14(3):347\u2013353","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"5","key":"13_CR77","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2015.2.FOCUS14847","volume":"38","author":"M Libby Kosnik-Infinger","year":"2015","unstructured":"Libby Kosnik-Infinger M, Gendron C, Gordon CB (2015) Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series. Neurosurg Focus 38(5):E10","journal-title":"Neurosurg Focus"},{"key":"13_CR78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2014.06.040","volume":"67","author":"J Liu","year":"2014","unstructured":"Liu J, Nam HK, Campbell C, Gasque KC, Millan JL, Hatch NE (2014) Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the alpl(\u2212\/\u2212) mouse model of infantile hypophosphatasia. Bone 67:81\u201394","journal-title":"Bone"},{"key":"13_CR79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bone.2015.05.005","volume":"78","author":"J Liu","year":"2015","unstructured":"Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millan JL, Hatch NE (2015) Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia. Bone 78:203\u2013211","journal-title":"Bone"},{"issue":"6","key":"13_CR80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1530\/ERC-12-0293","volume":"19","author":"MB Lodish","year":"2012","unstructured":"Lodish MB, Dagalakis U, Sinaii N, Bornstein E, Kim A, Lokie KB, Baldwin AM, Reynolds JC, Dombi E, Stratakis CA et al (2012) Bone mineral density in children and young adults with neurofibromatosis type 1. Endocr Relat Cancer 19(6):817\u2013825","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"13_CR81","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","volume":"29","author":"L Lopez-Delgado","year":"2018","unstructured":"Lopez-Delgado L, Riancho-Zarrabeitia L, Garcia-Unzueta MT, Tenorio JA, Garcia-Hoyos M, Lapunzina P, Valero C, Riancho JA (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 29(9):2147\u20132150","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"6","key":"13_CR82","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cell.2007.11.033","volume":"131","author":"TW Mak","year":"2007","unstructured":"Mak TW (2007) Gene targeting in embryonic stem cells scores a knockout in Stockholm. Cell 131(6):1027\u20131031","journal-title":"Cell"},{"issue":"6","key":"13_CR83","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1042\/bj0181354","volume":"18","author":"M Martland","year":"1924","unstructured":"Martland M, Robison R (1924) The possible significance of hexosephosphoric esters in ossification: part v. the enzyme in the early stages of bone development. Biochem J 18(6):1354\u20131357","journal-title":"Biochem J"},{"issue":"4","key":"13_CR84","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj0200847","volume":"20","author":"M Martland","year":"1926","unstructured":"Martland M, Robison R (1926) Possible significance of hexosephosphoric esters in ossification: part vi. Phosphoric esters in blood-plasma. Biochem J 20(4):847\u2013855","journal-title":"Biochem J"},{"issue":"3","key":"13_CR85","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj0210665","volume":"21","author":"M Martland","year":"1927","unstructured":"Martland M, Robison R (1927) The possible significance of hexosephosphoric esters in ossification: part vii. The bone phosphatase. Biochem J 21(3):665\u2013674","journal-title":"Biochem J"},{"issue":"2","key":"13_CR86","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/bj0230237","volume":"23","author":"M Martland","year":"1929","unstructured":"Martland M, Robison R (1929) The preparation and use of the bone phosphatase. Biochem J 23(2):237\u2013242","journal-title":"Biochem J"},{"issue":"11","key":"13_CR87","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1089\/hum.2010.210","volume":"22","author":"T Matsumoto","year":"2011","unstructured":"Matsumoto T, Miyake K, Yamamoto S, Orimo H, Miyake N, Odagaki Y, Adachi K, Iijima O, Narisawa S, Millan JL et al (2011) Rescue of severe infantile hypophosphatasia mice by aav-mediated sustained expression of soluble alkaline phosphatase. Hum Gene Ther 22(11):1355\u20131364","journal-title":"Hum Gene Ther"},{"issue":"4","key":"13_CR88","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0022034510393517","volume":"90","author":"MD McKee","year":"2011","unstructured":"McKee MD, Nakano Y, Masica DL, Gray JJ, Lemire I, Heft R, Whyte MP, Crine P, Millan JL (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90(4):470\u2013476","journal-title":"J Dent Res"},{"issue":"1","key":"13_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","volume":"231","author":"JL Meyer","year":"1984","unstructured":"Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231(1):1\u20138","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"13_CR90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-4165(84)90284-8","volume":"799","author":"JL Meyer","year":"1984","unstructured":"Meyer JL, Fleisch H (1984) Calcification inhibitors in rat and human serum and plasma. Biochim Biophys Acta 799(2):115\u2013121","journal-title":"Biochim Biophys Acta"},{"key":"13_CR91","doi-asserted-by":"crossref","DOI":"10.1002\/3527608060","volume-title":"Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology","author":"JL Mill\u00e1n","year":"2006","unstructured":"Mill\u00e1n JL (2006) Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Wiley-VCH, Weinheim"},{"issue":"4","key":"13_CR92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299\u2013306","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"13_CR93","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Millan","year":"2016","unstructured":"Millan JL, Whyte MP (2016) Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98(4):398\u2013416","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"13_CR94","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","volume":"23","author":"JL Millan","year":"2008","unstructured":"Millan JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Camacho NP, McKee MD et al (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23(6):777\u2013787","journal-title":"J Bone Miner Res"},{"key":"13_CR95","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bonr.2016.08.004","volume":"5","author":"M Mori","year":"2016","unstructured":"Mori M, DeArmey SL, Weber TJ, Kishnani PS (2016) Case series: odontohypophosphatasia or missed diagnosis of childhood\/adult-onset hypophosphatasia?\u2013call for a long-term follow-up of premature loss of primary teeth. Bone Rep 5:228\u2013232","journal-title":"Bone Rep"},{"issue":"5S2","key":"13_CR96","doi-asserted-by":"crossref","first-page":"5S51","DOI":"10.1016\/S0929-693X(18)30014-9","volume":"24","author":"E Mornet","year":"2017","unstructured":"Mornet E (2017) Genetics of hypophosphatasia. Arch Pediatr 24(5S2):5S51\u201355S56","journal-title":"Arch Pediatr"},{"issue":"3","key":"13_CR97","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the european population. Ann Hum Genet 75(3):439\u2013445","journal-title":"Ann Hum Genet"},{"issue":"9","key":"13_CR98","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ecm mineralization to bone. Genes Dev 19(9):1093\u20131104","journal-title":"Genes Dev"},{"key":"13_CR99","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1038\/mtm.2015.59","volume":"3","author":"A Nakamura-Takahashi","year":"2016","unstructured":"Nakamura-Takahashi A, Miyake K, Watanabe A, Hirai Y, Iijima O, Miyake N, Adachi K, Nitahara-Kasahara Y, Kinoshita H, Noguchi T et al (2016) Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary aav8 vector. Mol Ther Methods Clin Dev 3:15059","journal-title":"Mol Ther Methods Clin Dev"},{"key":"13_CR100","first-page":"161","volume":"8","author":"HK Nam","year":"2017","unstructured":"Nam HK, Sharma M, Liu J, Hatch NE (2017) Tissue nonspecific alkaline phosphatase (tnap) regulates cranial base growth and synchondrosis maturation. Front Physiol 8:161","journal-title":"Front Physiol"},{"issue":"3","key":"13_CR101","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","volume":"208","author":"S Narisawa","year":"1997","unstructured":"Narisawa S, Frohlander N, Millan JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208(3):432\u2013446","journal-title":"Dev Dyn"},{"issue":"1","key":"13_CR102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y","volume":"193","author":"S Narisawa","year":"2001","unstructured":"Narisawa S, Wennberg C, Millan JL (2001) Abnormal vitamin b6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol 193(1):125\u2013133","journal-title":"J Pathol"},{"issue":"21","key":"13_CR103","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1128\/MCB.23.21.7525-7530.2003","volume":"23","author":"S Narisawa","year":"2003","unstructured":"Narisawa S, Huang L, Iwasaki A, Hasegawa H, Alpers D, Mill\u00e1n J (2003) Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 23(21):7525\u20137530","journal-title":"Mol Cell Biol"},{"issue":"3","key":"13_CR104","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","volume":"88","author":"T Nishioka","year":"2006","unstructured":"Nishioka T, Tomatsu S, Gutierrez MA, Miyamoto K, Trandafirescu GG, Lopez PL, Grubb JH, Kanai R, Kobayashi H, Yamaguchi S et al (2006) Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab 88(3):244\u2013255","journal-title":"Mol Genet Metab"},{"issue":"12","key":"13_CR105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/154405910208101204","volume":"81","author":"FH Nociti Jr","year":"2002","unstructured":"Nociti FH Jr, Berry JE, Foster BL, Gurley KA, Kingsley DM, Takata T, Miyauchi M, Somerman MJ (2002) Cementum: a phosphate-sensitive tissue. J Dent Res 81(12):817\u2013821","journal-title":"J Dent Res"},{"key":"13_CR106","doi-asserted-by":"crossref","unstructured":"Offiah AC, Vockley J, Munns CF, Murotsuki J. 2018. Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives. Pediatr Radiol","DOI":"10.1007\/s00247-018-4239-0"},{"issue":"2","key":"13_CR107","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10545-013-9646-7","volume":"37","author":"H Oikawa","year":"2014","unstructured":"Oikawa H, Tomatsu S, Haupt B, Montano AM, Shimada T, Sly WS (2014) Enzyme replacement therapy on hypophosphatasia mouse model. J Inherit Metab Dis 37(2):309\u2013317","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"13_CR108","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jre.12412","volume":"52","author":"R Okawa","year":"2017","unstructured":"Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, Shimada T, Okada T, Ozono K, Ooshima T et al (2017a) Gene therapy improves dental manifestations in hypophosphatasia model mice. J Periodontal Res 52(3):471\u2013478","journal-title":"J Periodontal Res"},{"issue":"3","key":"13_CR109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pdj.2017.04.002","volume":"27","author":"R Okawa","year":"2017","unstructured":"Okawa R, Kokomoto K, Yamamura-Miyazaki N, Michigami T, Nakano K (2017b) Oral findings in patient with lethal hypophosphatasia treated with enzyme replacement therapy. Pediatr Dent J 27(3):153\u2013156","journal-title":"Pediatr Dent J"},{"issue":"3","key":"13_CR110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00431-015-2641-2","volume":"175","author":"Y Okazaki","year":"2016","unstructured":"Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K (2016) Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Eur J Pediatr 175(3):433\u2013437","journal-title":"Eur J Pediatr"},{"issue":"3","key":"13_CR111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1297\/cpe.27.179","volume":"27","author":"M Oyachi","year":"2018","unstructured":"Oyachi M, Harada D, Sakamoto N, Ueyama K, Kondo K, Kishimoto K, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M et al (2018) A case of perinatal hypophosphatasia with a novel mutation in the alpl gene: clinical course and review of the literature. Clin Pediatr Endocrinol 27(3):179\u2013186","journal-title":"Clin Pediatr Endocrinol"},{"issue":"1","key":"13_CR112","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.198226","volume":"344","author":"E Peters","year":"2013","unstructured":"Peters E, van Elsas A, Heemskerk S, Jonk L, van der Hoeven J, Arend J, Masereeuw R, Pickkers P (2013) Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury. J Pharmacol Exp Ther 344(1):2\u20137","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"13_CR113","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.ajkd.2013.11.027","volume":"63","author":"E Peters","year":"2014","unstructured":"Peters E, Heemskerk S, Masereeuw R, Pickkers P (2014a) Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients. Am J Kidney Dis 63(6):1038\u20131048","journal-title":"Am J Kidney Dis"},{"issue":"1\u20134","key":"13_CR114","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000363256","volume":"127","author":"E Peters","year":"2014","unstructured":"Peters E, Masereeuw R, Pickkers P (2014b) The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury. Nephron Clin Pract 127(1\u20134):144\u2013148","journal-title":"Nephron Clin Pract"},{"key":"13_CR115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.taap.2016.10.015","volume":"313","author":"E Peters","year":"2016","unstructured":"Peters E, Ergin B, Kandil A, Gurel-Gurevin E, van Elsas A, Masereeuw R, Pickkers P, Ince C (2016a) Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury. Toxicol Appl Pharmacol 313:88\u201396","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"13_CR116","doi-asserted-by":"crossref","first-page":"e012371","DOI":"10.1136\/bmjopen-2016-012371","volume":"6","author":"E Peters","year":"2016","unstructured":"Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA, Arend J, Pickkers P (2016b) Study protocol for a multicentre randomised controlled trial: safety, tolerability, efficacy and quality of life of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury (stop-aki). BMJ Open 6(9):e012371","journal-title":"BMJ Open"},{"issue":"1","key":"13_CR117","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2016.06.010","volume":"119","author":"D Phillips","year":"2016","unstructured":"Phillips D, Case LE, Griffin D, Hamilton K, Lara SL, Leiro B, Monfreda J, Westlake E, Kishnani PS (2016) Physical therapy management of infants and children with hypophosphatasia. Mol Genet Metab 119(1):14\u201319","journal-title":"Mol Genet Metab"},{"issue":"3","key":"13_CR118","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/PRM-170523","volume":"11","author":"D Phillips","year":"2018","unstructured":"Phillips D, Griffin D, Przybylski T, Morrison E, Reeves AL, Vallee M, Fujita KP, Madson KL (2018) Development and validation of a modified performance-oriented mobility assessment tool for assessing mobility in children with hypophosphatasia. J Pediatr Rehabil Med 11(3):187\u2013192","journal-title":"J Pediatr Rehabil Med"},{"issue":"1","key":"13_CR119","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/cc11159","volume":"16","author":"P Pickkers","year":"2012","unstructured":"Pickkers P, Heemskerk S, Schouten J, Laterre PF, Vincent JL, Beishuizen A, Jorens PG, Spapen H, Bulitta M, Peters WH et al (2012) Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care 16(1):R14","journal-title":"Crit Care"},{"issue":"6","key":"13_CR120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0036-1593532","volume":"47","author":"M Poryo","year":"2016","unstructured":"Poryo M, Meyer S, Eymann R, Yilmaz U, Nemat S, Rohrer T (2016) Clinical images: a cloudy skull-hypophosphatasia as reason for copper-beaten skull. Neuropediatrics 47(6):410","journal-title":"Neuropediatrics"},{"issue":"2","key":"13_CR121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/jpem-2016-0092","volume":"30","author":"HG Poyrazoglu","year":"2017","unstructured":"Poyrazoglu HG, Bas VN, Arslan A, Bastug F, Canpolat M, Per H, Gumus H, Kumandas S (2017) Bone mineral density and bone metabolic markers\u2019 status in children with neurofibromatosis type 1. J Pediatr Endocrinol Metab: JPEM 30(2):175\u2013180","journal-title":"J Pediatr Endocrinol Metab: JPEM"},{"key":"13_CR122","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-4-6","volume":"4","author":"A Reibel","year":"2009","unstructured":"Reibel A, Maniere MC, Clauss F, Droz D, Alembik Y, Mornet E, Bloch-Zupan A (2009) Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis 4:6","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"13_CR123","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/js.2017-00307","volume":"1","author":"H Remde","year":"2017","unstructured":"Remde H, Cooper MS, Quinkler M (2017) Successful asfotase alfa treatment in an adult dialysis patient with childhood-onset hypophosphatasia. J Endocr Soc 1(9):1188\u20131193","journal-title":"J Endocr Soc"},{"issue":"3","key":"13_CR124","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2017.12.001","volume":"85","author":"M Righetti","year":"2018","unstructured":"Righetti M, Wach J, Desmarchelier R, Coury F (2018) Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Joint Bone Spine 85(3):365\u2013367","journal-title":"Joint Bone Spine"},{"issue":"2","key":"13_CR125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1042\/bj0170286","volume":"17","author":"R Robison","year":"1923","unstructured":"Robison R (1923) The possible significance of hexosephosphoric esters in ossification. Biochem J 17(2):286\u2013293","journal-title":"Biochem J"},{"issue":"3\u20134","key":"13_CR126","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1042\/bj0180740","volume":"18","author":"R Robison","year":"1924","unstructured":"Robison R, Soames KM (1924) The possible significance of hexosephosphoric esters in ossification: part ii. The phosphoric esterase of ossifying cartilage. Biochem J 18(3\u20134):740\u2013754","journal-title":"Biochem J"},{"issue":"1","key":"13_CR127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/bj0190153","volume":"19","author":"R Robison","year":"1925","unstructured":"Robison R, Soames KM (1925) A chemical study of defective ossification in rachitic animals. Biochem J 19(1):153\u2013161","journal-title":"Biochem J"},{"issue":"6","key":"13_CR128","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1042\/bj0241927","volume":"24","author":"R Robison","year":"1930","unstructured":"Robison R, Macleod M, Rosenheim AH (1930) The possible significance of hexosephosphoric esters in ossification: calcification in vitro. Biochem J 24(6):1927\u20131941","journal-title":"Biochem J"},{"issue":"1","key":"13_CR129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11657-018-0507-8","volume":"13","author":"G Rodari","year":"2018","unstructured":"Rodari G, Scuvera G, Ulivieri FM, Profka E, Menni F, Saletti V, Esposito S, Bergamaschi S, Ferrante E, Eller-Vainicher C et al (2018) Progressive bone impairment with age and pubertal development in neurofibromatosis type i. Arch Osteoporos 13(1):93","journal-title":"Arch Osteoporos"},{"issue":"12","key":"13_CR130","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1902\/jop.2011.110103","volume":"82","author":"TL Rodrigues","year":"2011","unstructured":"Rodrigues TL, Nagatomo KJ, Foster BL, Nociti FH, Somerman MJ (2011) Modulation of phosphate\/pyrophosphate metabolism to regenerate the periodontium: a novel in vivo approach. J Periodontol 82(12):1757\u20131766","journal-title":"J Periodontol"},{"key":"13_CR02","doi-asserted-by":"crossref","unstructured":"Rodrigues TL, Georgetti AP, Martins L, Pereira Neto JS, Foster BL, Nociti FH Jr (2012, June) Clinical correlate: Cementum and periodontal defects resulting from odontohypophosphatasia predispose for premature tooth loss. In: Somerman MJ, LK MC (eds) Mineralized tissues in Oral and craniofacial science: biological principles and clinical correlates","DOI":"10.1002\/9781118704868.ch21"},{"issue":"7","key":"13_CR131","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.arcped.2018.08.002","volume":"25","author":"H Rougier","year":"2018","unstructured":"Rougier H, Desrumaux A, Bouchon N, Wroblewski I, Pin I, Nugues F, Mornet E, Baujat G (2018) Enzyme-replacement therapy in perinatal hypophosphatasia: case report and review of the literature. Arch Pediatr 25(7):442\u2013447","journal-title":"Arch Pediatr"},{"issue":"6","key":"13_CR132","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/BF00442478","volume":"147","author":"PM Royce","year":"1988","unstructured":"Royce PM, Blumberg A, Zurbrugg RP, Zimmermann A, Colombo JP, Steinmann B (1988) Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia. Eur J Pediatr 147(6):626\u2013631","journal-title":"Eur J Pediatr"},{"issue":"1","key":"13_CR133","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13023-018-0866-7","volume":"13","author":"ET Rush","year":"2018","unstructured":"Rush ET (2018) Childhood hypophosphatasia: to treat or not to treat. Orphanet J Rare Dis 13(1):116","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"13_CR134","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63996-X","volume":"158","author":"F Rutsch","year":"2001","unstructured":"Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, Kalhoff H, Sano K, Boisvert W, Superti-Furga A et al (2001) Pc-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158(2):543\u2013554","journal-title":"Am J Pathol"},{"issue":"4","key":"13_CR135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, Schauer G, Lehmann M, Roscioli T, Schnabel D et al (2003) Mutations in enpp1 are associated with \u2018idiopathic\u2019 infantile arterial calcification. Nat Genet 34(4):379\u2013381","journal-title":"Nat Genet"},{"key":"13_CR136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpeds.2016.01.045","volume":"172","author":"V Saraff","year":"2016","unstructured":"Saraff V, Narayanan VK, Lawson AJ, Shaw NJ, Preece MA, Hogler W (2016) A diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia. J Pediatr 172:181\u2013186.e181","journal-title":"J Pediatr"},{"issue":"9","key":"13_CR137","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, R\u00fcther W, Amling M, Barvencik F (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28(9):2653\u20132662","journal-title":"Osteoporos Int"},{"issue":"3","key":"13_CR138","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jbspin.2012.07.010","volume":"80","author":"C Schnabel","year":"2013","unstructured":"Schnabel C, Jett K, Friedman JM, Frieling I, Kruse HP, Mautner V (2013) Effect of vitamin d3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study. Joint Bone Spine 80(3):315\u2013319","journal-title":"Joint Bone Spine"},{"issue":"19","key":"13_CR139","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddw248","volume":"25","author":"A Sebastian-Serrano","year":"2016","unstructured":"Sebastian-Serrano A, Engel T, de Diego-Garcia L, Olivos-Ore LA, Arribas-Blazquez M, Martinez-Frailes C, Perez-Diaz C, Millan JL, Artalejo AR, Miras-Portugal MT et al (2016) Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation. Hum Mol Genet 25(19):4143\u20134156","journal-title":"Hum Mol Genet"},{"issue":"1","key":"13_CR140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/adc.65.1.130","volume":"65","author":"S Seshia","year":"1990","unstructured":"Seshia S, Derbyshire G, Haworth J, Hoogstraten J (1990) Myopathy with hypophosphatasia. Arch Dis Child 65(1):130\u2013131","journal-title":"Arch Dis Child"},{"issue":"2","key":"13_CR141","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/1097-0029(20001015)51:2<121::AID-JEMT3>3.0.CO;2-8","volume":"51","author":"J Shao","year":"2000","unstructured":"Shao J, Engle M, Xie Q, Schmidt R, Narisawa S, Millan J, Alpers D (2000) Effect of tissue non-specific alkaline phosphatase in maintenance of structure of murine colon and stomach. Microsc Res Tech 51(2):121\u2013128","journal-title":"Microsc Res Tech"},{"key":"13_CR142","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"Shapiro JR, Lewiecki EM (2017) Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32:1977\u20131980","journal-title":"J Bone Miner Res"},{"issue":"5","key":"13_CR143","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00000542-197911000-00017","volume":"51","author":"Y Shimada","year":"1979","unstructured":"Shimada Y, Yoshiya I, Tanaka K, Yamazaki T, Kumon K (1979) Crying vital capacity and maximal inspiratory pressure as clinical indicators of readiness for weaning of infants less than a year of age. Anesthesiology 51(5):456\u2013459","journal-title":"Anesthesiology"},{"issue":"2","key":"13_CR144","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jbmr.3225","volume":"33","author":"AF Siller","year":"2018","unstructured":"Siller AF, Whyte MP (2018) Alkaline phosphatase: discovery and naming of our favorite enzyme. J Bone Miner Res 33(2):362\u2013364","journal-title":"J Bone Miner Res"},{"key":"13_CR145","first-page":"581","volume":"251","author":"AI Skoultchi","year":"1987","unstructured":"Skoultchi AI, Nandi A, Roginski RS, Gregg RG, Smithies O (1987) Expression of genes inserted at the human beta-globin locus by homologous recombination. Prog Clin Biol Res 251:581\u2013594","journal-title":"Prog Clin Biol Res"},{"key":"13_CR146","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinbiochem.2018.04.024","volume":"58","author":"AG Sofronescu","year":"2018","unstructured":"Sofronescu AG, Ross M, Rush E, Goldner W (2018) Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa). Clin Biochem 58:118\u2013121","journal-title":"Clin Biochem"},{"issue":"3","key":"13_CR147","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/JOE-12-0143","volume":"214","author":"KA Staines","year":"2012","unstructured":"Staines KA, MacRae VE, Farquharson C (2012) The importance of the sibling family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol 214(3):241\u2013255","journal-title":"J Endocrinol"},{"issue":"27","key":"13_CR148","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1523\/JNEUROSCI.0133-13.2013","volume":"33","author":"SE Street","year":"2013","unstructured":"Street SE, Kramer NJ, Walsh PL, Taylor-Blake B, Yadav MC, King IF, Vihko P, Wightman RM, Millan JL, Zylka MJ (2013) Tissue-nonspecific alkaline phosphatase acts redundantly with pap and nt5e to generate adenosine in the dorsal spinal cord. J Neurosci 33(27):11314\u201311322","journal-title":"J Neurosci"},{"issue":"4","key":"13_CR149","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/hum.2011.148","volume":"23","author":"H Sugano","year":"2012","unstructured":"Sugano H, Matsumoto T, Miyake K, Watanabe A, Iijima O, Migita M, Narisawa S, Millan JL, Fukunaga Y, Shimada T (2012) Successful gene therapy in utero for lethal murine hypophosphatasia. Hum Gene Ther 23(4):399\u2013406","journal-title":"Hum Gene Ther"},{"issue":"5","key":"13_CR150","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27(5):987\u2013994","journal-title":"J Bone Miner Res"},{"issue":"1","key":"13_CR151","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","volume":"281","author":"R Terkeltaub","year":"2001","unstructured":"Terkeltaub R (2001) Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Phys Cell Physiol 281(1):C1\u2013C11","journal-title":"Am J Phys Cell Physiol"},{"key":"13_CR152","volume-title":"Genetics of bone biology and skeletal disease","author":"RV Thakker","year":"2017","unstructured":"Thakker RV, Whyte MP, Eisman J, Igarashi T (2017) Genetics of bone biology and skeletal disease. Academic, San Diego"},{"issue":"3","key":"13_CR153","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(87)90646-5","volume":"51","author":"KR Thomas","year":"1987","unstructured":"Thomas KR, Capecchi MR (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51(3):503\u2013512","journal-title":"Cell"},{"key":"13_CR154","unstructured":"Tomazos IC, Moseley S, L\u2019Italien G, Da Silva HG, Phillips D (2017) Improvements in the 6-minute walk test and correlation with quality-of-life measures in children and adults with hypophosphatasia treated with asfotase alfa. Paper presented at: ENDO 2017. Orlando"},{"issue":"9","key":"13_CR155","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.29271\/jcpsp.2018.09.S198","volume":"28","author":"SA Ucakturk","year":"2018","unstructured":"Ucakturk SA, Elmaogullari S, Unal S, Gonulal D, Mengen E (2018) Enzyme replacement therapy in hypophosphatasia. J Coll Physicians Surg Pak 28(9):S198\u2013S200","journal-title":"J Coll Physicians Surg Pak"},{"issue":"11","key":"13_CR156","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00431-002-0978-9","volume":"161","author":"S Unger","year":"2002","unstructured":"Unger S, Mornet E, Mundlos S, Blaser S, Cole DE (2002) Severe cleidocranial dysplasia can mimic hypophosphatasia. Eur J Pediatr 161(11):623\u2013626","journal-title":"Eur J Pediatr"},{"issue":"2","key":"13_CR157","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcb.25291","volume":"117","author":"M Vallet","year":"2016","unstructured":"Vallet M, Ralston SH (2016) Biology and treatment of paget\u2019s disease of bone. J Cell Biochem 117(2):289\u2013299","journal-title":"J Cell Biochem"},{"issue":"11","key":"13_CR158","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/154405910508401110","volume":"84","author":"T van den Bos","year":"2005","unstructured":"van den Bos T, Handoko G, Niehof A, Ryan LM, Coburn SP, Whyte MP, Beertsen W (2005) Cementum and dentin in hypophosphatasia. J Dent Res 84(11):1021\u20131025","journal-title":"J Dent Res"},{"key":"13_CR159","unstructured":"Vidmar AP, Ng C, Ganster A, Pitukcheewanont P (2017) Asfotase alfa treatment of an african-american infant with perinatal hypophosphatasia and homozygous hemoglobin sc disease. IBMS BoneKey 14"},{"issue":"20","key":"13_CR160","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","volume":"20","author":"W Wang","year":"2011","unstructured":"Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F (2011) Mice lacking nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type i. Hum Mol Genet 20(20):3910\u20133924","journal-title":"Hum Mol Genet"},{"issue":"1","key":"13_CR161","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0995-45","volume":"11","author":"KG Waymire","year":"1995","unstructured":"Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin b-6. Nat Genet 11(1):45\u201351","journal-title":"Nat Genet"},{"issue":"10","key":"13_CR162","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","volume":"65","author":"TJ Weber","year":"2016","unstructured":"Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS (2016) Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism 65(10):1522\u20131530","journal-title":"Metabolism"},{"issue":"20","key":"13_CR163","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","volume":"85","author":"MJ Weiss","year":"1988","unstructured":"Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H (1988) A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85(20):7666\u20137669","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20134","key":"13_CR164","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03008208909050000","volume":"21","author":"MJ Weiss","year":"1989","unstructured":"Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor R, Harris H (1989a) First identification of a gene defect for hypophosphatasia: evidence that alkaline phosphatase acts in skeletal mineralization. Connect Tissue Res 21(1\u20134):99\u2013104. discussion 104\u2013106","journal-title":"Connect Tissue Res"},{"issue":"5","key":"13_CR165","first-page":"686","volume":"44","author":"MJ Weiss","year":"1989","unstructured":"Weiss MJ, Ray K, Fallon MD, Whyte MP, Fedde KN, Lafferty MA, Mulivor RA, Harris H (1989b) Analysis of liver\/bone\/kidney alkaline phosphatase mrna, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia. Am J Hum Genet 44(5):686\u2013694","journal-title":"Am J Hum Genet"},{"issue":"10","key":"13_CR166","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/jbmr.454","volume":"26","author":"D Wenkert","year":"2011","unstructured":"Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP (2011) Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 26(10):2389\u20132398","journal-title":"J Bone Miner Res"},{"issue":"10","key":"13_CR167","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.2000.15.10.1879","volume":"15","author":"C Wennberg","year":"2000","unstructured":"Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millan JL (2000) Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15(10):1879\u20131888","journal-title":"J Bone Miner Res"},{"key":"13_CR168","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/B978-0-12-382040-2.10028-0","volume-title":"Pediatric bone: biology & diseases","author":"MP Whyte","year":"2012","unstructured":"Whyte MP (2012) Hypophosphatasia. In: Glorieux FH, Pettifor JM, Juppner H (eds) Pediatric bone: biology & diseases, 2nd edn. Academic, London, pp 771\u2013794","edition":"2"},{"issue":"4","key":"13_CR169","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia\u00a0\u2013 aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"13_CR170","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res 32(4):667\u2013675","journal-title":"J Bone Miner Res"},{"issue":"3","key":"13_CR171","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","volume":"101","author":"MP Whyte","year":"1982","unstructured":"Whyte MP, Valdes R Jr, Ryan LM, McAlister WH (1982) Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with paget bone disease. J Pediatr 101(3):379\u2013386","journal-title":"J Pediatr"},{"issue":"6","key":"13_CR172","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","volume":"105","author":"MP Whyte","year":"1984","unstructured":"Whyte MP, McAlister WH, Patton LS, Magill HL, Fallon MD, Lorentz WB Jr, Herrod HG (1984) Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich paget plasma: results in three additional patients. J Pediatr 105(6):926\u2013933","journal-title":"J Pediatr"},{"issue":"1","key":"13_CR173","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3476(86)80773-9","volume":"108","author":"MP Whyte","year":"1986","unstructured":"Whyte MP, Magill HL, Fallon MD, Herrod HG (1986) Infantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphatase. J Pediatr 108(1):82\u201388","journal-title":"J Pediatr"},{"issue":"4","key":"13_CR174","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","volume":"18","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP, Ryan LM, Miller CR, Gottesman GS, Smith AK et al (2003) Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18(4):624\u2013636","journal-title":"J Bone Miner Res"},{"issue":"4","key":"13_CR175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92(4):1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"13_CR176","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1359\/jbmr.090308","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP, Wenkert D, McAlister WH, Mughal MZ, Freemont AJ, Whitehouse R, Baildam EM, Coburn SP, Ryan LM, Mumm S (2009) Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res 24(8):1493\u20131505","journal-title":"J Bone Miner Res"},{"issue":"10","key":"13_CR177","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366(10):904\u2013913","journal-title":"N Engl J Med"},{"key":"13_CR178","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL (2015a) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients. Bone 75:229\u2013239","journal-title":"Bone"},{"key":"13_CR179","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL et al (2015b) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75:229\u2013239","journal-title":"Bone"},{"issue":"9","key":"13_CR180","doi-asserted-by":"crossref","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP (2016a) Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1(9):e85971","journal-title":"JCI Insight"},{"issue":"1","key":"13_CR181","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C (2016b) Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab 101(1):334\u2013342","journal-title":"J Clin Endocrinol Metab"},{"key":"13_CR182","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2018.01.022","volume":"110","author":"MP Whyte","year":"2018","unstructured":"Whyte MP, Coburn SP, Ryan LM, Ericson KL, Zhang F (2018) Hypophosphatasia: biochemical hallmarks validate the expanded pediatric clinical nosology. Bone 110:96\u2013106","journal-title":"Bone"},{"issue":"1","key":"13_CR183","doi-asserted-by":"crossref","first-page":"16945","DOI":"10.1038\/s41598-018-35079-y","volume":"8","author":"DK Williams","year":"2018","unstructured":"Williams DK, Pinzon C, Huggins S, Pryor JH, Falck A, Herman F, Oldeschulte J, Chavez MB, Foster BL, White SH et al (2018) Genetic engineering a large animal model of human hypophosphatasia in sheep. Sci Rep 8(1):16945","journal-title":"Sci Rep"},{"issue":"2","key":"13_CR184","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2004-0251","volume":"90","author":"MH Wyckoff","year":"2005","unstructured":"Wyckoff MH, El-Turk C, Laptook A, Timmons C, Gannon FH, Zhang X, Mumm S, Whyte MP (2005) Neonatal lethal osteochondrodysplasia with low serum levels of alkaline phosphatase and osteocalcin. J Clin Endocrinol Metab 90(2):1233\u20131240","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"13_CR185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2011.03.770","volume":"49","author":"MC Yadav","year":"2011","unstructured":"Yadav MC, Lemire I, Leonard P, Boileau G, Blond L, Beliveau M, Cory E, Sah RL, Whyte MP, Crine P et al (2011) Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone 49(2):250\u2013256","journal-title":"Bone"},{"issue":"8","key":"13_CR186","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/jbmr.1619","volume":"27","author":"MC Yadav","year":"2012","unstructured":"Yadav MC, de Oliveira RC, Foster BL, Fong H, Cory E, Narisawa S, Sah RL, Somerman M, Whyte MP, Millan JL (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27(8):1722\u20131734","journal-title":"J Bone Miner Res"},{"issue":"1","key":"13_CR187","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.201","volume":"26","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto S, Orimo H, Matsumoto T, Iijima O, Narisawa S, Maeda T, Millan JL, Shimada T (2011) Prolonged survival and phenotypic correction of akp2(\u2212\/\u2212) hypophosphatasia mice by lentiviral gene therapy. J Bone Miner Res 26(1):135\u2013142","journal-title":"J Bone Miner Res"},{"issue":"9","key":"13_CR188","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/ajmg.a.32202","volume":"146A","author":"A Zankl","year":"2008","unstructured":"Zankl A, Mornet E, Wong S (2008) Specific ultrasonographic features of perinatal lethal hypophosphatasia. Am J Med Genet A 146A(9):1200\u20131204","journal-title":"Am J Med Genet A"},{"issue":"1","key":"13_CR189","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ijos.2014.62","volume":"7","author":"LE Zweifler","year":"2015","unstructured":"Zweifler LE, Patel MK, Nociti FH Jr, Wimer HF, Millan JL, Somerman MJ, Foster BL (2015) Counter-regulatory phosphatases tnap and npp1 temporally regulate tooth root cementogenesis. Int J Oral Sci 7(1):27\u201341","journal-title":"Int J Oral Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Therapeutic Enzymes: Function and Clinical Implications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7709-9_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T18:40:12Z","timestamp":1647974412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-7709-9_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811377082","9789811377099"],"references-count":191,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7709-9_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"4 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}